Tuesday

3rd Aug 2021

EU vaccine negotiator: joint-purchase doses will 'come first'

  • The second quarter of 2021, April to June, 'is going to be the quarter with many doses,' the EU's top negotiator on vaccines contracts, Sandra Gallina, told MEPs (Photo: European Commission)

The EU's top negotiator on vaccine contracts, Sandra Gallina, has defended the EU's collective approach on vaccines, arguing that doses collectively purchased will "come first", ahead of those secured under bilateral deals.

During a hearing in the European Parliament's environment and public health committee, Gallina said she was "confused" by recent reports of bilateral deals because the EU's overall strategy forbids member states from negotiating individually.

Read and decide

Join EUobserver today

Become an expert on Europe

Get instant access to all articles — and 20 years of archives. 14-day free trial.

... or subscribe as a group

  • 'If I buy billions of doses [on paper] but they are not delivered, what's the use?' said Gallina (Photo: EC - Audiovisual Service)

"I have not seen yet one [bilateral deal], I do not think I will ever. They do not exist based on what I have been told, [but in any case], the quantities [purchased] for Europe come first," Gallina told MEPs on Tuesday (12 January).

Last week, Germany said it had secured 30 million additional vaccine doses for its own citizens under a separate agreement with BioNTech - an announcement that explicitly appears on the German health ministry website.

However, the commission has refused to clarify whether the German deal is legal under the EU rules.

Meanwhile, the president of Cyprus, Nicos Anastasiades, has also said that his country is in talks with Israel for extra vaccines under its own deal, arguing that EU's supplies are "not enough for rapid and mass vaccinations".

In response to critics, Gallina said that Brussels bought "as much as was offered," considering prices and timely deliveries.

"If I buy billions of doses [on paper] but they are not delivered, what's the use?" she also said.

The commission, on behalf of member states, has sealed deals with six companies for up to 2.3 billion vaccine doses.

Currently, the BioNTech-Pfizer and Moderna vaccines are the only jabs authorised in the EU.

With two doses per person needed for both authorised vaccines, the European Union could vaccinate at least 380 million people - since the total of vaccine doses purchased by the EU is 760 million (600 million from BioNtech-Pfizer and 160 million from Moderna).

Thus, the EU's procurement would cover approximately 80 percent of the European population.

"This has been a united effort that has gotten us the doses that as a single country, big as the country can be, would have never received," Gallina warned.

Meanwhile, the commission expects to see faster deliveries of vaccines from April, as already agreed in the existing contracts.

The second quarter "is going to be the quarter with many doses," Gallina said, adding that quick vaccination programs will help to control the transmission of the new variant of Covid-19.

The European Medicine Agency is currently studying the efficacy of the vaccine developed by AstraZeneca and Oxford University - expected to become the third vaccine authorised in the EU before the end of the month.

Additionally, the commission is also trying to close deals with French company Valneva and the US firm Novavax for up to 230 million vaccines.

Vaccines are distributed to EU countries on a population-based pro-rata basis, although member states can trade among themselves.

Calls for transparency

MEPs told the commission official that the lack of transparency regarding vaccine contracts had triggered both high expectations and uncertainty among EU citizens, while fuelling disinformation.

"Transparency is at most crucial, [otherwise] we are opening the possibilities for all nationalists' frames [of the situation]," Green MEP Bas Eeckhout warned the commission.

A reading room has been made available for those MEPs who want to review vaccine contracts, but only CureVac has agreed so far to make the agreements available for lawmakers.

"More companies should follow this example," said EU health commissioner Stella Kyriakides.

Agenda

Vaccines in focus in the EU This WEEK

The European Parliament's environment committee will hear from the person who negotiated the vaccine contracts, commission director-general of health and food safety, Sandra Gallina.

Commission silent as Germany buys own vaccines

The European Commission refused to comment on whether a bilateral deal between Germany and BioNTech for 30 million additional vaccines is a breach of EU collective purchase agreements - which forbid member states from negotiating separate deals.

EU agency authorises Moderna vaccine amid blame-game

The European Medicines Agency has authorised the use of the Covid-19 vaccine developed by US company Moderna - while the EU is involved in a blame-game over a sluggish vaccine rollout across member states.

Agenda

EU leaders seek to speed up vaccinations This WEEK

EU leaders talk vaccines, while the Portugues EU presidency introduces itself to MEPs. Joe Biden will be inaugurated as president of the United States, and the EU hopes this will mark a new beginning for EU-US relations.

EU targets vaccinating 70% of adults by summer

The European Commission has announced targets to accelerate the roll-out of vaccination, and the intention of "a common approach" on possible vaccine certificates. Both topics will be discussed by EU leaders on Thursday.

News in Brief

  1. Poland, Czech Republic offer visa to Belarus 'asylum' athlete
  2. 200,000 protest against French Covid-19 health pass
  3. Greece issued nearly 10,000 migrant detention orders
  4. Officials worried at infection-surge on Greek holiday islands
  5. EU calls on online platforms to tackle vaccine hesitancy
  6. Russia accused of falling short on Sputnik V deliveries
  7. France: UK quarantine rules 'discriminatory'
  8. Italy's government reaches deal on judicial reform

Delta variant poses 'mandatory' vaccination dilemma for EU

The spread of the more contagious Delta variant has prompted authorities in member states to accelerate inoculation campaigns, and even make vaccination mandatory - in a bid to halt the new surge of cases and avoid lockdowns in the autumn.

Stakeholders' Highlights

  1. Nordic Council of MinistersNineteen demands by Nordic young people to save biodiversity
  2. Nordic Council of MinistersSustainable public procurement is an effective way to achieve global goals
  3. Nordic Council of MinistersNordic Council enters into formal relations with European Parliament
  4. Nordic Council of MinistersWomen more active in violent extremist circles than first assumed
  5. Nordic Council of MinistersDigitalisation can help us pick up the green pace
  6. Nordic Council of MinistersCOVID19 is a wake-up call in the fight against antibiotic resistance

Latest News

  1. NGOs rescue around 800 people in Mediterranean
  2. Report: Pfizer and Moderna raise vaccine prices for EU
  3. Amazon deforestation and the EU-Mercosur trade deal
  4. Moldova facing Europe's worst demographic crisis
  5. Malta responsible for journalist's death, inquiry finds
  6. Can Greece work with Biden to solve the West Balkans impasse?
  7. EU and UK frustrated at US travel ban extension
  8. Polish judges rally behind EU court ruling

Join EUobserver

Support quality EU news

Join us